2 results match your criteria: "Kawasaki University of Medical Science[Affiliation]"
The Mechanism of the Synergistic Anticancer Effect of CDDP and EPA in the TE1 Cell Line.
Anticancer Res
April 2021
Department of Digestive Surgery, Kawasaki Medical School, Okayama, Japan.
Background/aim: Eicosapentaenoic acid (EPA) is an unsaturated fatty acid with various bioactivities, including antitumor effects. We previously reported a synergistic antitumor effect of cisplatin (CDDP) and EPA. Here, we examined the underlying mechanism.
View Article and Find Full Text PDFSynergistic Effect of Eicosapentaenoic Acid on Antiproliferative Action of Anticancer Drugs in a Cancer Cell Line Model.
Ann Nutr Metab
June 2019
Department of Clinical Nutrition, Faculty of Health Science and Technology, Kawasaki University of Medical Science, Kurashiki, Japan.
Background/aims: It has been found experimentally and clinically that eicosapentaenoic acid (EPA) exerts an anticancer effect and that it has a minimal adverse event profile relative to other anticancer drugs. Any synergy between EPA and other anticancer drugs could be of therapeutic relevance, especially in elderly or high-risk patients. Therefore, we investigated the synergism between anticancer drugs and EPA experimentally.
View Article and Find Full Text PDF